Elderly patients aged 65–75 years with glioblastoma multiforme may benefit from long course radiation therapy with temozolomide
Crossref DOI link: https://doi.org/10.1007/s11060-014-1472-8
Published Online: 2014-05-15
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gzell, C.
Wheeler, H.
Guo, L.
Kastelan, M.
Back, M.
Text and Data Mining valid from 2014-05-15
